How I treat influenza in patients with hematologic malignancies

Citations of this article
Mendeley users who have this article in their library.


The 2009 H1N1 influenza pandemic has heightened the interest of clinicians for options in the prevention and management of influenza virus infection in immunocompromised patients. Even before the emergence of the novel 2009 H1N1 strain, influenza disease was a serious complication in patients with hematologic malignancies receiving chemotherapy or undergoing hematopoietic cell transplantation. Here we review the clinical manifestations of seasonal and 2009 H1N1 influenza and discuss current diagnosis, antiviral treatment, and prophylaxis options. We also summarize infection control and vaccination strategies for patients, family members, and caregivers. © 2010 by The American Society of Hematology.




Casper, C., Englund, J., & Boeckh, M. (2010). How I treat influenza in patients with hematologic malignancies. Blood, 115(7), 1331–1342.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free